Results 201 to 210 of about 554,589 (315)

Toward Understanding the Biology of a Complex Phenotype: Rat Strain and Substrain Differences in the Sensorimotor Gating-Disruptive Effects of Dopamine Agonists [PDF]

, 2000
Neal R. Swerdlow, Zoe Allen Martinez, Faith M. Hanlon, Amanda Platten, Marjan Farid, Pamela P. Auerbach, David Braff, Mark A. Geyer   +7 more
openalex   +1 more source

Single local delivery of 5′‐(N‐ethylcarboxamido)adenosine depots ameliorates myocardial infarction‐induced cardiac dysfunction via the enhancement of mitostasis

VIEW, EarlyView.
To overcome the limitations of exogenous adenosine in myocardial ischemia treatment, an adenosine derivative 5′‐(N‐ethylcarboxamido) adenosine (NECA)‐loaded poly(lactic‐co‐glycolic acid) micro‐depots was fabricated for myocardial infarction (MI) therapy.
Shibo Wei, Tiep Tien Nguyen, Yan Zhang, Wonyoung Park, Nhu‐Nam Nguyen, Jiwoo Kim, Yunju Jo, Chang‐Myung Oh, Doyoun Kim, Jin Han, Ki‐Tae Ha, Jee‐Heon Jeong, Dongryeol Ryu   +12 more
wiley   +1 more source

Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma. [PDF]

Cureus, 2021
Khalil G, Khan FA, Jamal QM, Saleem A, Masroor H, Abbas K.   +5 more
europepmc   +1 more source

Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder

Pharmacogenomics and Personalized Medicine, 2014
Florence Levy School of Psychiatry, University of New South Wales and Prince of Wales Hospital, Sydney, Australia Abstract: This review examines molecular genetic studies shown to be of importance in the etiology of attention-deficit/hyperactivity ...
Levy F
doaj  

Effects of dopamine and alpha-2 adrenoceptor agonists and antagonists on ganglionic transmission in the cardiac sympathetic nerves of the dog.

, 1991
Osamu Mukaiyama, Tomohiko Kimura, Susumu Satoh   +2 more
openalex   +1 more source

Dopamine agonists: their role in the treatment of Parkinson's disease [PDF]

, 2000
David J. Brooks
openalex   +1 more source

Development and application of microfluidic sweat detection technology in mental health monitoring

VIEW, EarlyView.
In this review, the authors emphasize the potential of microfluidic sweat detection technology in the field of mental health monitoring. The work explores the intricate relationship between psychological disorders, such as depression and anxiety, and their physiological impact, emphasizing how these conditions can influence systemic health. Furthermore,
Danni Zhao, Ran Chen, Shuyue Jiang, Weiwei Xie, Kaihuan Zhang, Jianlong Zhao, Shilun Feng, Shengtai Bian   +7 more
wiley   +1 more source

Analysis of the hypothalamic oxytocin system and oxytocin receptor‐expressing astrocytes in a mouse model of Prader–Willi syndrome

Journal of Neuroendocrinology, Volume 34, Issue 12, December 2022., 2022
If and how genetic disorders such as Prader‐Willi (PWS) or Schaaf‐Yang (SYS) syndromes affect oxytocinergic signaling is not well studied. In this study we used our established and well‐characterised Magel2 KO mouse model and analysed the number of oxytocin (OT) cells and OT receptor‐expressing (OTR) astrocytes.
Ferdinand Althammer, Moritz Claudius Wimmer, Quirin Krabichler, Stephanie Küppers, Jonas Schimmer, Henning Fröhlich, Laura Dötsch, Tim Gruber, Selina Wunsch, Tim Schubert, Matthew K. Kirchner, Javier E. Stern, Alexandre Charlet, Valery Grinevich, Christian P. Schaaf   +14 more
wiley   +1 more source

The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis. [PDF]

BMC Endocr Disord, 2021
Zou Y, Li D, Gu J, Chen S, Wen X, Dong J, Jiang X.   +6 more
europepmc   +1 more source

Effect of Aripiprazole on 5-HT2Receptor–mediated Wet-Dog Shake Responses and Disruption of Prepulse Inhibition in Rats

Journal of Pharmacological Sciences, 2008
Aripiprazole, an atypical antipsychotic drug, is a D2dopamine–receptor partial agonist, but also has affinity to several serotonin receptors (5-HT1A,2A,2C,7).
Shuntaro Kohnomi, Katsuya Suemaru, Hiromu Kawasaki, Hiroaki Araki   +3 more
doaj